fbpx

NBCA Supports VENUS

NBCA Supports VENUS

The National Blood Clot Alliance (NBCA) strongly supports biomedical research focused on blood clots, regardless of cause. While much is understood about clots, many important questions remain unanswered.

That is why NBCA is proud to be a supporter of VENUS, the Venous thromboEmbolism Network U.S. The members of this research collaborative are physician-scientists employed at academic medical centers and other non-commercial research institutions. Currently, 90 investigators working at more than 60 institutions participate in VENUS.

VENUS members organize collaborative, multi-institutional research projects, including clinical trials, and apply for grant funds to support this work. You can read more about VENUS here.


To read more about clinical trials in general, visit NBCA’s Clinical Trials page, where you also can link to and learn more about clinical trials focused on blood clots.

Click here to read MASAB Memos about the results from some recent studies in venous thromboembolism.

 

Current News

Sens. Grassley and Luján Announce Passage of Resolution Recognizing DVT and PE Awareness Month 2023

WASHINGTON – On Tuesday, a resolution recognizing March as Deep Vein Thrombosis and Pulmonary Embolism Awareness Month passed with unanimous…

NBCA Advocates For $5 Million in Federal Blood Clot Awareness and Education Funding

WASHINGTON — Katie Hoff, Olympic swimmer and National Blood Clot Alliance Ambassador, spoke Thursday morning before the U.S. House of…